[Prevention of genital erosions during treatments with foscarnet of cytomegalovirus infections in AIDS].
Lowenstein
W
W
Fadlallah
J P
JP
Roudière
L
L
Deneux
C
C
Haas
C
C
Durand
H
H
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology*; D017245:Foscarnet; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000150:complications; D010409:Penile Diseases / Q000139:chemically induced*; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid
Prévention des érosions génitales lors des traitements par foscarnet des infections à cytomégalovirus du SIDA.